Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women. - Connors KP; Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Redican S; Nicolau DP (Antimicrobial agents and chemotherapy, 2014)